| Literature DB >> 30948141 |
Paulina Núñez F1, Rodrigo Quera P2, Fernando Gomollón3.
Abstract
The association between inflammatory bowel disease (IBD) and primary sclerosing cholangitis should be considered a distinct clinical entity. This association involves genetic abnormalities, epidemiological factors (more common in men, with no a geographical pattern) and, commonly, subclinical inflammation, predominance of the right colon (endoscopic and histological), backwash ileitis and rectal sparing. Furthermore, there is an increased risk of colorectal cancer and cholangiocarcinoma. The aim of this review is to show how IBD influences the progression of this entity, transplantation requirements and recurrence. We also discuss the current evidence on the use of biological therapy in this group of patients.Entities:
Keywords: Colangitis esclerosante primaria; Colitis ulcerosa; Crohn's disease; Enfermedad de Crohn; Enfermedad inflamatoria intestinal; Inflammatory bowel disease; Primary sclerosing cholangitis; Ulcerative colitis
Mesh:
Year: 2019 PMID: 30948141 DOI: 10.1016/j.gastrohep.2019.02.004
Source DB: PubMed Journal: Gastroenterol Hepatol ISSN: 0210-5705 Impact factor: 2.102